Compare Otsuka Holdings Co., Ltd. with Similar Stocks
Dashboard
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 27.59
2
Healthy long term growth as Operating profit has grown by an annual rate 15.14%
3
Flat results in Dec 25
4
With ROE of 12.76%, it has a fair valuation with a 1.99 Price to Book Value
5
Majority shareholders : FIIs
6
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 6,114,055 Million (Large Cap)
16.00
NA
0.00%
-0.14
12.89%
1.97
Revenue and Profits:
Net Sales:
630,342 Million
(Quarterly Results - Mar 2026)
Net Profit:
99,295 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
17.99%
0%
17.99%
6 Months
31.72%
0%
31.72%
1 Year
52.36%
0%
52.36%
2 Years
72.7%
0%
72.7%
3 Years
134.42%
0%
134.42%
4 Years
143.75%
0%
143.75%
5 Years
156.57%
0%
156.57%
Otsuka Holdings Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.65%
EBIT Growth (5y)
15.14%
EBIT to Interest (avg)
27.59
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.80
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
20.44%
Pledged Shares
0
Institutional Holding
0.28%
ROCE (avg)
12.29%
ROE (avg)
10.53%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.99
EV to EBIT
13.70
EV to EBITDA
10.69
EV to Capital Employed
2.13
EV to Sales
2.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.58%
ROE (Latest)
12.76%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Bullish
OBV
Mildly Bullish
Bullish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 3 Foreign Institutions (0.28%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
630,342.00
582,840.00
8.15%
Operating Profit (PBDIT) excl Other Income
145,029.00
142,452.00
1.81%
Interest
2,043.00
13,745.00
-85.14%
Exceptional Items
-288.00
-93.00
-209.68%
Consolidate Net Profit
99,295.00
85,967.00
15.50%
Operating Profit Margin (Excl OI)
181.90%
197.90%
-1.60%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 8.15% vs 12.19% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 15.50% vs 8.96% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,468,892.00
2,329,861.00
5.97%
Operating Profit (PBDIT) excl Other Income
528,601.00
504,830.00
4.71%
Interest
7,181.00
7,130.00
0.72%
Exceptional Items
-28,409.00
-124,666.00
77.21%
Consolidate Net Profit
366,216.00
347,271.00
5.46%
Operating Profit Margin (Excl OI)
167.10%
170.30%
-0.32%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 5.97% vs 15.42% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 5.46% vs 176.71% in Dec 2024
About Otsuka Holdings Co., Ltd. 
Otsuka Holdings Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






